Tenapanor Reduces Serum Phosphate in Patients on Dialysis Tenapanor Reduces Serum Phosphate in Patients on Dialysis
The experimental agent significantly reduced elevated serum phosphate in patients undergoing maintenance dialysis for end-stage renal disease; adverse events were infrequent in the phase 3 trial.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Nephrology News Source Type: news